Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
Bio Preventive Medicine Corp. Ltd.
6f-1, No. 18 Taiyuan St.,
30265
Zhubei City, Hsinchu
Taiwan
Taiwan
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Our range of products
Product categories
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.01 Immuno assay testing
Immuno assay testing
Our products
Product category: Immuno assay testing
DNlite-IVD103: novel diagnostic solution for precision DKD management
BPM’s expertise in Diabetic Kidney Disease (DKD) and non-proteinuric renal disease led to the development of first breakthrough IVD product, DNlite-IVD103, which detecting a post translational modification of a DKD biomarker and identified by large urinary proteomic studies (+3,000 patients). DNlite-IVD103 is a non-invasive urinary ELISA test for predicting/ monitoring the progression of DKD, and has obtained CE IVD mark, Malaysia MDA and other regulatory-approvals for global market.
DNlite-IVD103:
DNlite-IVD103:
- Non-invasive urine ELISA test: perfect for clinical practice
- Predict & monitor progressive decliner of DKD months to years earlier
- Risk assessment for kidney function loss
- Precision DKD management & complementary test
- Proven quality (CE IVD marked & ISO13485/ GMP)
About us
Company details
Bio Preventive Medicine (BPM) is a leading company in renal biomarker area. As an innovative and clinical staged biotech company, BPM has focus on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially among the fields of disease’s early detection and prevention in diabetes related complications, such as CKD and CVD, kidney injury, and oncology (upper GI cancer).
To advance precision medicine and reduce healthcare burden globally in chronic diseases and oncology, BPM develops clinically proven biomarkers and high value-added diagnostic products, that enable unprecedented efficiencies in the development of therapies. BPM constantly contribute its expertise and is seeking to partner and collaborate with leading industry organizations.
For more information, please visit: https://www.bpmbiotech.com/
To advance precision medicine and reduce healthcare burden globally in chronic diseases and oncology, BPM develops clinically proven biomarkers and high value-added diagnostic products, that enable unprecedented efficiencies in the development of therapies. BPM constantly contribute its expertise and is seeking to partner and collaborate with leading industry organizations.
For more information, please visit: https://www.bpmbiotech.com/
Company data
Area of businessDiagnostics